SEC Form D · filed September 29, 2015
Deciphera Pharmaceuticals, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Thomas F. Kelly · Waltham, MAExecJohn A. Martin · Waltham, MADirectorDennis A. Walsh · Waltham, MADirectorDaniel F. Flynn, Ph.D · Waltham, MAExecLiam A. Ratcliffe, M.D., Ph.D · Waltham, MADirectorJames A. Bristol, Ph.D · Waltham, MADirectorOliver F. Rosen, M.D · Waltham, MAExecMichael Taylor · Waltham, MAExec · DirectorRajesh Khona · Ebene, O4Exec · DirectorNavin Dussoruth · Ebene, O4DirectorAnil Narang · Ebene, O4ExecAlok Kejriwal · Ebene, O4DirectorJoe Anstine · Columbus, OHExec · DirectorCharles J. O'Hanlon · Pittsburgh, PADirectorWilliam J. Mitchell · Pittsburgh, PAExec · DirectorKirsten Green · New York, NYExecDavid Fialkow · New York, NYExecRobert Wolfson · New York, NYDirectorDouglas Ricket · Saratoga, CADirectorDelfino Hernandez Iii · Mill Creek, WAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗